GPCRStructure Therapeutics Inc.

Healthcare
$25.51+8.2% 1Y

The financials

Structure Therapeutics Inc. by the numbers

The next results filing is expected around Nov 5, 2026, the same week as a year ago.

Structure Therapeutics Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$119M−$70Mn/a
Net income−$106M−$62Mn/a
Diluted EPS−$0.49−$0.36n/a

Biotechnology

Ranks #194 of 196 by RyuScore

Compare peers
DYN+1.7%
Dyne Therapeutics, Inc.
QURE+0.22%
uniQure N.V.
BEAM+4.6%
Beam Therapeutics Inc.
IDYA+0.21%
IDEAYA Biosciences, Inc.
ELVN+0.94%
Enliven Therapeutics, Inc.
ARQT+8.5%
Arcutis Biotherapeutics, Inc.